Mercado farmacéutico de tamaño mediano: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00018321
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 203
Buy Now

Se espera que el mercado farmacéutico de tamaño mediano crezca de 690.105,2 millones de dólares en 2022 a 1.000.584,3 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 6,4 % de 2022 a 2028.

Los ingresos, el área de terapia, el gasto en I+D y el alcance se encuentran entre los segmentos críticos de la industria farmacéutica global. La empresa farmacéutica mediana se encuentra entre las tres categorías de la industria farmacéutica. Hace hincapié en el desarrollo de medicamentos genéricos y el desarrollo de terapias para enfermedades raras. Las medianas empresas farmacéuticas obtienen ingresos de entre 1.000 y 10.000 millones de dólares. Se espera que la creciente prevalencia de enfermedades crónicas, el rápido aumento de la población de edad avanzada y el creciente número de lanzamientos y aprobaciones de productos contribuyan al crecimiento del mercado farmacéutico de tamaño mediano.

El informe proporciona información y un análisis en profundidad de el mercado farmacéutico de tamaño mediano, enfatizando varios parámetros como las tendencias del mercado, los avances tecnológicos y la dinámica del mercado. También proporciona el análisis del panorama competitivo de los principales actores del mercado y el impacto de la pandemia de COVID-19 en el mercado en las principales regiones. La pandemia de COVID-19 afectó tres aspectos principales de la economía global: la manufactura, la cadena de suministro y los mercados financieros. Sin embargo, el impacto de la pandemia en el mercado farmacéutico de tamaño medio fue inicialmente negativo, pero más tarde se volvió positivo. Al comienzo de la pandemia de COVID-19, el mercado farmacéutico mediano de las regiones enfrentó numerosos desafíos a corto y largo plazo, incluidos impactos directos en la producción y la demanda, impactos financieros en las empresas manufactureras e interrupciones en la cadena de suministro y mercados. En los mercados farmacéuticos de tamaño mediano, los efectos de la pandemia eran casi predecibles. El resultado fue una demanda y financiación extremadamente altas para productos esenciales para la atención y el tratamiento de los pacientes, como vacunas para enfermedades infecciosas, enfermedades respiratorias, diabetes e influenza. Sin embargo, los presupuestos para medicamentos no esenciales eran limitados o no estaban disponibles.

Perspectivas estratégicas

Dado que las regiones cambiaron rápidamente la gestión de los ensayos, la mayoría puede brindar los servicios de ensayos clínicos según las necesidades de los clientes. necesidades. Actualmente, las empresas de biotecnología están iniciando ensayos clínicos en las regiones. Desde el brote inicial, la situación en Asia Pacífico ha mejorado. En mayo de 2020, el 97 % de los sitios reabrieron para visitas de pacientes y el 83 % de los sitios están abiertos para visitas de CRA en el sitio. Además, los hospitales en China están abiertos en un 90% para visitas de pacientes hospitalizados y ambulatorios en comparación con años anteriores. Además, los sitios clínicos están volviendo a sus operaciones normales.

Según la región, el mercado farmacéutico de tamaño mediano está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica.

regiones lucrativas para el mercado farmacéutico de tamaño mediano

Perspectivas del mercado
La creciente prevalencia de trastornos crónicos impulsa el mercado farmacéutico de tamaño mediano

El envejecimiento de la población y el cambio de comportamiento social contribuyen al aumento constante de problemas de salud comunes y costosos a largo plazo. Con la acelerada urbanización, la gente está adoptando un estilo de vida sedentario, lo que aumenta las tasas de obesidad y casos de enfermedades como la diabetes. Según la Organización Mundial de la Salud, se prevé que la prevalencia de enfermedades crónicas aumentará un 57% para 2026. La creciente demanda de sistemas de atención de salud debido a la creciente incidencia de enfermedades crónicas se ha convertido en una preocupación importante. Por ejemplo, según la Federación Internacional de Diabetes (FID), el número de personas con diabetes en América del Norte era de aproximadamente 46 millones en 2019 y se prevé que aumente a 62 millones para 2045. El aumento en la prevalencia de la enfermedad sería de aproximadamente el 35% durante el periodo previsto. Las pandemias ejercen tensiones perturbadoras periódicas y enormes sobre los sistemas de fitness. Las instituciones de atención médica de todo el mundo necesitan estar preparadas para contener colectivamente los brotes una vez que ocurran. Por lo tanto, la creciente prevalencia de trastornos crónicos impulsa el crecimiento del mercado farmacéutico de tamaño mediano.

Información basada en tipos

Según el tipo, el mercado farmacéutico de tamaño mediano se divide en prescripción y en el mostrador. En 2022, el segmento de venta libre representó una mayor participación de mercado. Se espera que sea uno de los segmentos de más rápido crecimiento. El crecimiento del mercado para el segmento se atribuye a la creciente asignación presupuestaria por parte de las empresas farmacéuticas para la comercialización de medicamentos y al mayor ingreso disponible.

Mercado farmacéutico de tamaño mediano, por tipo: 2022 y 2028

Perspectivas basadas en el tipo de desarrollo de fármacos

Según el tipo de desarrollo de fármaco, el mercado farmacéutico de tamaño medio se divide en interno y subcontratado . El segmento de subcontratación tuvo una mayor participación de mercado en 2022. El aumento de la demanda de organizaciones de fabricación y desarrollo por contrato (CDMO) y el creciente número de nuevos participantes en el mercado impulsarían el crecimiento del mercado para el segmento de subcontratación durante el período de pronóstico.

Información basada en la formulación

Según la formulación, el mercado farmacéutico de tamaño mediano se segmenta en tabletas y tabletas. cápsulas, inyectables, aerosoles y otras formulaciones. Las tabletas y El segmento de cápsulas tuvo la mayor participación de mercado en 2022. Se prevé que el amplio uso de tabletas y cápsulas en tratamientos a largo plazo, el fácil uso de aerosoles y las formulaciones inyectables innovadoras, como jeringas precargadas y de dosis fija, impulsen el crecimiento del mercado. para tabletas y segmento de cápsulas durante el período de pronóstico.

Información basada en la clase de terapia

Según la clase de terapia, el mercado farmacéutico de tamaño mediano se segmenta en enfermedades cardiovasculares, manejo del dolor, diabetes, cáncer, y otras condiciones. El segmento de diabetes tuvo la mayor cuota de mercado en 2022. Debido a la creciente prevalencia de enfermedades crónicas y la creciente incidencia del cáncer, se prevé que el mercado para el segmento del cáncer crezca rápidamente durante el período de pronóstico.

El Los actores del mercado farmacéutico de tamaño mediano están adoptando estrategias orgánicas e inorgánicas, incluido el lanzamiento y la expansión de productos, para expandir su huella y su cartera de productos a nivel mundial. COMPAÑÍA DAIICHI SANKYO, LIMITADA; Eisai Co., Ltd.; Regeneron Pharmaceuticals, Inc; Bausch Health Companies Inc.; Industrias farmacéuticas Sun Ltd; Alexion Pharmaceuticals, Inc.; Mallinckrodt; Endo Pharmaceuticals Inc.; Les Laboratories Servier; y UCB SA se encuentran entre las empresas líderes en el mercado farmacéutico de tamaño mediano.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the top companies that hold the market share in mid-size pharmaceuticals market?

DAIICHI SANKYO COMPANY LIMITED and Regeneron Pharmaceuticals, Inc, are the top two companies that hold huge market shares in the mid-size pharmaceuticals market.

Who are the key players in the mid-size pharmaceuticals market?

The mid-size pharmaceuticals market majorly consists of players such as DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Alexion Pharmaceuticals, Inc., Mallinckrodt, Endo Pharmaceuticals Inc., Les Laboratories Servier, UCB S.A. amongst others.

Which drug development type held the largest share in the mid-size pharmaceuticals market?

In 2021, the hip outsource held the largest share of the market, by drug development type. It is expected to report a higher CAGR of 6.7% during 2021–2028.

Which type led the mid-size pharmaceuticals market?

In 2021, the over-the-counter segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factors for the growth of the over-the-counter segment are increasing budget allocation by pharmaceutical companies for the marketing of drugs, higher disposable income, and the rising prevalence of chronic diseases. Moreover, the increasing self-medication tendency among the population is one of the significant factors in the growth of the over-the-counter (OTC) segment.

What is the market CAGR value of the mid-size pharmaceuticals market during the forecast period?

The CAGR value of the mid-size pharmaceuticals market during the forecasted period of 2021–2028 is 6.4%.

What are the driving factors for the mid-size pharmaceuticals market across the globe?

Key factors that are driving the growth of this market are the growing prevalence of prevalence of chronic disorders and rising number of product launches and approvals are expected to drive the market during the forecast period.

What is mid-size pharmaceutical?

Mid-size pharmaceutical is among the three categories of pharmaceutical industry. The global pharmaceutical industry is segmented on the basis of their revenue, therapy area, R&D expenditure, reach etc. The mid-sized pharmaceutical companies are those companies which have their revenue in range of US$ 1 billion to US$ 10 billion. Mid-size pharmaceutical emphasizes on generic drug and development of rare disease therapies.

The List of Companies - Mid-Size Pharmaceutical Market

  1. DAIICHI SANKYO COMPANY LIMITED
  2. Eisai Co., Ltd.
  3. Bausch Health Companies Inc.
  4. Regeneron Pharmaceuticals, Inc
  5. Sun Pharmaceutical Industries Ltd
  6. Alexion Pharmaceuticals, Inc.
  7. Mallinckrodt
  8. Endo Pharmaceuticals Inc.
  9. Les Laboratories Servier
  10. UCB S.A.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports